Retractable Technologies, Inc. (NYSE:RVP – Get Free Report) CEO Thomas J. Shaw acquired 18,411 shares of the business’s stock in a transaction dated Monday, January 6th. The shares were acquired at an average cost of $0.78 per share, with a total value of $14,360.58. Following the acquisition, the chief executive officer now directly owns 14,947,978 shares of the company’s stock, valued at $11,659,422.84. This represents a 0.12 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
Retractable Technologies Stock Down 7.7 %
Shares of NYSE:RVP opened at $0.75 on Friday. The firm has a fifty day moving average of $0.66 and a 200 day moving average of $0.85. Retractable Technologies, Inc. has a 52-week low of $0.56 and a 52-week high of $1.34. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.92 and a current ratio of 8.57. The firm has a market capitalization of $22.52 million, a PE ratio of -1.39 and a beta of 1.94.
Wall Street Analyst Weigh In
Separately, StockNews.com initiated coverage on shares of Retractable Technologies in a research note on Monday. They issued a “hold” rating for the company.
Hedge Funds Weigh In On Retractable Technologies
A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC bought a new position in Retractable Technologies, Inc. (NYSE:RVP – Free Report) in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned about 0.12% of Retractable Technologies at the end of the most recent reporting period. 7.58% of the stock is currently owned by institutional investors and hedge funds.
Retractable Technologies Company Profile
Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.
Read More
- Five stocks we like better than Retractable Technologies
- 3 Best Fintech Stocks for a Portfolio Boost
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- How to invest in marijuana stocks in 7 steps
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.